The chairman is eager to send a message for the coming year.
Release time:
2021-02-10
seize the day and seize the hour for development, and it is urgent to improve the ability.
enterprise needs to redouble its efforts. chairman
earnestly hopes to send a message to the group company's 2020 annual summary and commendation conference held on February 3, Jiang xiaomeng, secretary of the party Committee and chairman of the group company, made the topic "seize the hour for development" in view of the market situation and existing problems faced by the company in that year, the summary speech of the meeting of "ability is urgent", from three aspects of analysis and elaboration, the company's work in 2021 put forward requirements.
The current achievements are not easy to come by, and the future risks are still in sight. Jiang Xiaomeng pointed out that the peak has made good achievements in the 13th Five Year Plan period, which is not only the result of persisting in strengthening the main business, grasping the layout and attaching importance to management, but also the achievements brought about by the joint efforts of all the peak people. However, the current China is facing a century of unprecedented changes, the world pattern has undergone great changes, the new coronary pneumonia epidemic global pandemic to accelerate the evolution of this great change, economic globalization encountered a countercurrent, economic downturn, and is entering a period of turbulent change, the economic situation is changing very fast. Under the new pattern of taking the domestic big cycle as the main body and the domestic and international double cycle, enterprises must grasp the "new rhythm" of the market and lay a good "advance quantity". Enterprises that meet the status quo and rest on their laurels will be eliminated by the market at any time. Judging from the situation of the peak itself, with the progress of the industry and the integration of enterprises, the existing advantages of the two main businesses have been overtaken or are being overtaken. What we can do is to establish a correct and realistic development direction as the premise, seize opportunities, make scientific layout, take the initiative to innovate, vigorously develop, solve problems in development through development, and enhance the core competitive advantages of enterprises through innovation.
Grasp the development and seize every minute. It is urgent to improve the ability. Jiang Xiaomeng believes that the next five years will be the historical intersection of the implementation of the 14th Five-Year Plan and the two 100-year goals. The economic work conferences of the Central Committee, Zhejiang Provincial Committee and Jinhua Municipal Committee have pointed out the direction for economic and social development at their respective levels. Enterprise managers must deeply understand the spirit of the relevant meetings and find out the focus of future development. Improve the organizational competitiveness, product competitiveness, innovation competitiveness, cultural competitiveness and talent competitiveness of the group company in an all-round way. From the perspective of the two main businesses of the peak, the problem of cement overcapacity has existed for a long time, and the best way to solve the problem of excess is merger and reorganization and transformation and upgrading to improve industrial concentration and market competitiveness. The peak cement sector should also seize the current opportunity to step up the layout. In the pharmaceutical industry, with the in-depth implementation of policies such as medical insurance negotiations and volume procurement, the competitive pressure of production enterprises has increased sharply. Peak Pharmaceutical must seize the time to build the cost and quality advantages of the production system in an all-round way, and use the speed, quality, curative effect and exclusive advantages in the field of innovative drugs to create the comparative competitive advantage of Peak Pharmaceutical.
The future of the enterprise is promising. We need to redouble our efforts. Jiang Xiaomeng pointed out that for the peak, only by doing familiar industries, doing good work, and making products with core competitiveness can we get better development. How to recreate advantages? The cement sector should speed up the rational layout, seize the advantages of resources, improve labor productivity through intelligent transformation, reduce costs and efficiency, reduce emissions through continuous upgrading of processes, and establish competitive advantages through the extension of the industrial chain such as aggregate production and solid hazardous waste treatment. The pharmaceutical industry should strengthen the introduction of innovative drugs and exclusive drugs to obtain incomparable product advantages. Taking advantage of the existing conditions for the integration of bulk drugs and preparations, the cost of centralized products should be minimized to ensure the competitive advantage in joint centralized procurement. Taking advantage of the tightening of environmental protection management and the tightening of approval for the production of bulk drugs, the cake of pharmaceutical intermediates and bulk drugs should be enlarged to create the second peak pharmaceutical industry.
For the specific work in 2021, Jiang Xiaomeng has made key requirements on the following aspects: strictly implement the company's annual work plan, layer upon layer of responsibilities, and ensure the completion of the target; Establish the concept of "everything for sales", improve the quality of operation, enhance the stickiness of customers, realize the advancement of sales, continuously improve the level of customer service, and achieve high returns with efficient management, high-quality service and high-quality products; Grasp the market demand, take the initiative to seize opportunities, speed up the layout of the cement industry and enhance competitiveness; adhere to innovation-driven and technology-led, seize the commanding heights of intelligent manufacturing, cement enterprises should build intelligent factories with high standards, and the pharmaceutical industry should strengthen the research and development of new drugs, speed up the progress of research and development, improve the level of research and development, and seize the market with innovative drugs; deepen strategic cooperation with universities and scientific research institutes, and use brains to attract wisdom to achieve mutual benefit and win-win; continue to promote green and environmentally friendly production to ensure safe and standardized growth; promote corporate culture, promote the growth of employees, and enhance employees' sense of identity and belonging to the company; strengthen the leadership of party building, establish a spirit of responsibility, and cultivate the idea of employees and the company to advance and retreat together, and share honor and disgrace, Create a good atmosphere of clean and upright.
Jiang Xiaomeng stressed that the realization of the grand blueprint for the future of the peak requires the joint efforts of every peak person. He hoped that all cadres and employees would show greater energy and courage in their future work to create a better tomorrow for the peak and themselves. (this newspaper reporter)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31